Durect Corp

NASDAQ:DRRX 4:00:00 PM EDT

4.64

-0.01 (-0.22%)

4:03:06 PM EDT: $4.88 +0.24 (+5.17%)

Market Cap (Intraday)	113.60M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.89 Million
Adjusted EPS	-$0.52

See more estimates

10-Day MA	$4.72
50-Day MA	$5.65
200-Day MA	$5.46

See more pivots

Durect Corp Stock, NASDAQ:DRRX

10260 Bubb Road, Cupertino, California 95014-4166

United States of America

Phone: +1.408.777.1417

Number of Employees: 79

http://www.durect.com

Description

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.